Cargando…

Biomarkers in precision therapy in colorectal cancer

Colorectal cancer (CRC) is the most commonly diagnosed cancer in Europe. Because CRC is also a major cause of cancer-related deaths worldwide, a lot of research has been focused on the discovery and development of biomarkers to improve the diagnostic process and to predict treatment outcomes. Up til...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reimers, Marlies S., Zeestraten, Eliane C.M., Kuppen, Peter J.K., Liefers, Gerrit Jan, van de Velde, Cornelis J.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937997/ https://www.ncbi.nlm.nih.gov/pubmed/24759962 http://dx.doi.org/10.1093/gastro/got022

Ejemplares similares

The Prognostic Value of the Apoptosis Pathway in Colorectal Cancer: A Review of the Literature on Biomarkers Identified by Immunohistochemistry
por: Zeestraten, Eliane C.M., et al.
Publicado: (2013)

Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
por: Reimers, Marlies S, et al.
Publicado: (2014)

Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients
por: Speetjens, Frank M., et al.
Publicado: (2008)

Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer
por: Benard, Anne, et al.
Publicado: (2014)

Copy number alterations and allelic ratio in relation to recurrence of rectal cancer
por: Goossens-Beumer, Inès J, et al.
Publicado: (2015)

FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer
por: Zeestraten, Eliane C. M., et al.
Publicado: (2011)

Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer
por: Mieog, J Sven D, et al.
Publicado: (2012)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer
por: Benard, Anne, et al.
Publicado: (2014)

NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
por: de Kruijf, Esther M, et al.
Publicado: (2012)

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study
por: Boonstra, Martin C, et al.
Publicado: (2014)

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis
por: Frouws, Martine A., et al.
Publicado: (2017)

Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
por: Blok, Erik J, et al.
Publicado: (2013)

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients
por: van Staalduinen, Jente, et al.
Publicado: (2016)

Risk Factors for Excess Mortality in the First Year After Curative Surgery for Colorectal Cancer
por: Gooiker, Gea A., et al.
Publicado: (2012)

Clinical impact of HLA class I expression in rectal cancer
por: Speetjens, Frank M., et al.
Publicado: (2007)

Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data
por: Trinh, Anne, et al.
Publicado: (2018)

The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
por: Engels, Charla C., et al.
Publicado: (2016)

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study
por: Lips, Daniel J, et al.
Publicado: (2011)

Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
por: Turano, Mimmo, et al.
Publicado: (2019)

Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins
por: Boonstra, Martin C., et al.
Publicado: (2016)

The CpG island methylator phenotype (CIMP) in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013)

Revising the Role of Integrin Subunit β4 Expression in Colon Cancer Progression and Survival
por: Rademaker, Eva, et al.
Publicado: (2022)

CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood
por: Krijgsman, Daniëlle, et al.
Publicado: (2020)

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?
por: Charehbili, Ayoub, et al.
Publicado: (2013)

Psychological distress and quality of life following positive fecal occult blood testing in colorectal cancer screening
por: Vermeer, Nina C. A., et al.
Publicado: (2020)

Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study
por: Peters, Inge T. A., et al.
Publicado: (2017)

Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells
por: de Geus, Susanna WL, et al.
Publicado: (2017)

High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
por: Derr, Remco S, et al.
Publicado: (2014)

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
por: Zhang, Xi, et al.
Publicado: (2023)

Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

Clinical implications of BRAF mutation test in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013)

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy
por: Boogerd, Leonora SF, et al.
Publicado: (2018)

Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer
por: de Heer, Pieter, et al.
Publicado: (2008)

The Homeobox Gene MEIS1 Is Methylated in BRAF (p.V600E) Mutated Colon Tumors
por: Dihal, Ashwin A., et al.
Publicado: (2013)

No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study
por: Frouws, Martine A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_33j63421kn63raltl8o9408bp0